Disclosed are methods of using proteasome inhibitors in combinations with other pharmaceutically active agents for treating viral hepatitis infections, for example, for treating therapy-resistant and -refractory viral hepatitis infections. The filler metal-forming composition comprises zinc optionally in combination with aluminum andor silicon, and further comprises at least one braze promoter selected from nickel, cobalt, iron and palladium. d) Application to the demodulation of a signal of CDMA type, or of UMTS type. A spin-on dielectric layer is formed on the substrate and the capacitor.